SBIR/STTR Research Award
STTR Phase I: Development of a Lead Optimization Chip for Drug Discovery
Award amount
$150,000Program and phase
STTR · Phase IAward year
2007Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- Solidus Biosciences, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- NSF 06-598
- Topic code
- BT
Research abstract
This Small Business Technology Transfer (STTR) Phase I research project aims to develop a new method for generating lead compounds by using enzymatic modification of compound sets.Availability of new methodology to generate biologically active compounds from existing molecules may enhance the success of the drug discovery process and may lead to the discovery of new and useful therapeutics.
Technology keywords
Not reported